Liu Sheng

Research areas: Surgical treatment of severe heart failure; surgical treatment of chronic thromboembolic pulmonary hypertension (CTEPH); surgical treatment of mitral valve repair; prediction and intervention of perioperative acute kidney injury in cardiovascular diseases.

Cutting-edge technology: While maintaining the top ranking nationwide in both surgical volume and quality, the team places greater emphasis on building research capabilities. The team has undertaken 2 National Key Research and Development Programs, 2 National Natural Science Foundation of China (NSFC) General Programs, and 2 NSFC Youth Programs, and has led research projects such as large animal experiments and clinical trials of the ECMO system, and research on new strategies to reduce postoperative re-intervention in degenerative mitral valve disease.

Areas of expertise: end-stage heart failure, heart transplantation, chronic thromboembolic pulmonary hypertension, and severe valvular heart disease.

Academic Highlights and Core Values: Deputy Director of the Surgical Management Committee, Deputy Director of the Adult Surgery Center, Director of the Third Adult Cardiac Surgery Ward, and Temporary Head of the Critical Heart Failure Treatment Center at Fuwai Hospital; Member of the American Association for Thoracic Surgery (AATS); Member of the National Heart Transplant Quality Control Expert Committee; and Vice Chairman of the Organ Transplantation Branch of the Beijing Medical Association. The team has 40 permanent members, 15 of whom hold senior professional titles. As of 2022, they have trained 7 doctoral students.